Subacute Weakness with Respiratory Decline: Timing the Workup
A 58-year-old man presents with 3 weeks of progressive symmetric proximal leg weakness, now unable to rise from a chair, with mild finger extension weakness. He reports a recent diarrheal illness 6 weeks ago. Reflexes are absent at the knees and ankles. He has no sensory symptoms, no cranial nerve deficits, and no autonomic complaints. Vital signs: BP 138/82, HR 88, SpO2 97% on room air, FVC 68% predicted, NIF -38 cmH2O. CK is 210 U/L. He has not had any imaging or electrodiagnostic testing yet. The resident asks whether to start IVIG tonight or wait for LP, MRI, and EMG/NCS.
1. How should the team weigh immediate empiric immunotherapy against completing the diagnostic evaluation? Frame the decision around what the FVC and NIF numbers mean and what treatable mimics must be excluded before committing to IVIG or plasma exchange.
Read the worked answer
The respiratory numbers are the pivot. An FVC of 68% predicted with NIF of -38 cmH2O is abnormal but not yet in the danger zone typically cited for impending ventilatory failure (roughly FVC <20 mL/kg or <1 L, NIF weaker than about -30 cmH2O, or a rapidly falling trend). This patient sits in a monitoring zone, not an intubate-now zone, which buys time for a focused workup.
Key reasoning:
- The phenotype (symmetric proximal-predominant weakness, areflexia, antecedent diarrheal illness, no sensory or autonomic features) is compatible with Guillain-Barre syndrome and with acute-onset CIDP, but also with several mimics that immunotherapy would not help or could harm.
- Treatable mimics that must be excluded or made unlikely before IVIG/PLEX: myasthenia gravis (would expect fatigability, ocular/bulbar involvement, and a positive icepack/edrophonium or antibody profile), botulism (descending, prominent bulbar/autonomic), acute porphyria (abdominal pain, psychiatric features, urine porphobilinogen), toxic exposures (organophosphates, lead), electrolyte disorders (hypokalemia, hypophosphatemia), inflammatory myopathy, and spinal cord or cauda equina lesions.
- LP with CSF protein/glucose/cell count and MRI spine help exclude inflammatory, infectious, and compressive causes. EMG/NCS confirms the pattern (demyelinating vs axonal vs myopathic) and can redirect therapy.
Practical answer: do not start IVIG reflexively tonight. Admit to a monitored bed, repeat FVC/NIF serially (every 4-6 hours initially), and pursue LP, MRI, and EMG urgently. If respiratory function declines or bulbar weakness emerges, treat empirically while results are pending, because the risk of aspiration/ventilatory failure outweighs the small risk of treating a mimic.
2. The next morning the FVC has fallen to 52% predicted and NIF to -28 cmH2O. EMG/NCS is still pending and LP is scheduled for the afternoon. What should change in management, and why?
Read the worked answer
The trend, not the absolute value, now drives the decision. A drop from 68% to 52% predicted FVC over roughly a day, with NIF weakening to -28 cmH2O, signals evolving respiratory muscle failure. This crosses into the range where elective intubation may be needed and where aspiration risk rises.
Reasoning and actions:
- Move to a higher level of monitoring (ICU or step-down) with continuous pulse oximetry and frequent (every 2-4 hours) FVC/NIF checks.
- Do not delay disease-modifying therapy for the LP. In a patient with a compatible phenotype and rapidly worsening respiratory function, empiric IVIG or plasma exchange is justified while confirmatory testing proceeds, because delay risks intubation and prolonged ventilation.
- IVIG and PLEX are considered roughly equivalent in efficacy for GBS; choice depends on availability, renal function, IgA status (IgA deficiency is a relative contraindication to IVIG), and hemodynamic stability.
- Continue to pursue LP and EMG in parallel; results still matter because they may reveal a mimic and change therapy.
- Anticipate autonomic instability and bulbar dysfunction; involve respiratory therapy and consider ICU-level airway planning if FVC continues to fall.
This is the judgment call the exam tests: the trigger for empiric treatment is a compatible clinical picture plus a declining respiratory trajectory, not a completed diagnostic panel.